Edgewise Therapeutics
Nicole Rempel Kilburn has an extensive background in regulatory affairs and program management within the pharmaceutical and biotech industry. With experience at companies like Edgewise Therapeutics, Clinipace, Navigen Pharmaceuticals, and more, Nicole has held various leadership roles throughout their career. Nicole holds a Master's degree in Microbiology & Immunology from Albert Einstein College of Medicine, a Bachelor's degree in Zoology from Colorado State University, and an MBA from the University of Utah - David Eccles School of Business.
This person is not in any teams
Edgewise Therapeutics
1 followers
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it’s Series B financing round which will support the advancement of Edgewise Therapeutic’s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company’s pipeline. The company’s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.